Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Moro-Sibilot

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Revue De Pneumologie Clinique|July 23, 2011
[What choice of first-line treatment?]D Moro-Sibilot
Revue De Pneumologie Clinique|April 4, 2007
[Second-line treatment of non-small-cell lung cancers]D Moro-Sibilot
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 10, 2001
[Respiratory carcinogenesis: epidemiologic and behavioral features, and evolution of concepts]D Moro-Sibilot
The European Respiratory Journal|October 1, 2003
Photodynamic therapy: where do we go from here?D Moro-Sibilot, C Brambilla
Journal De Radiologie|January 4, 2003
[Screening for bronchial carcinoma]B Milleron, D Moro-Sibilot,
Revue Des Maladies Respiratoires|January 14, 2003
[Screening for bronchial carcinoma]D Moro-Sibilot, B Milleron,
Revue Des Maladies Respiratoires|December 13, 2005
[Chemotherapy for metastatic non-small cell lung cancer]M Pérol, D Moro-Sibilot
The European Respiratory Journal|April 2, 2009
First- and second-line therapy for advanced nonsmall cell lung cancerJ-P Sculier, D Moro-Sibilot
Revue Des Maladies Respiratoires|October 23, 2010
[Targeting insulin-like growth factors in the treatment of cancer]D Moro-Sibilot, M Coudurier, S Lantuejoul
Revue De Pneumologie Clinique|April 9, 2013
[Crizotinib: a targeted therapy in advanced ALK-positive non-small cell lung cancer]A-C Toffart, L Sakhri, D Moro-Sibilot
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Revue De Pneumologie Clinique|July 23, 2011
[What choice of first-line treatment?]D Moro-Sibilot
Revue De Pneumologie Clinique|April 4, 2007
[Second-line treatment of non-small-cell lung cancers]D Moro-Sibilot
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 10, 2001
[Respiratory carcinogenesis: epidemiologic and behavioral features, and evolution of concepts]D Moro-Sibilot
The European Respiratory Journal|October 1, 2003
Photodynamic therapy: where do we go from here?D Moro-Sibilot, C Brambilla
Journal De Radiologie|January 4, 2003
[Screening for bronchial carcinoma]B Milleron, D Moro-Sibilot,
Revue Des Maladies Respiratoires|January 14, 2003
[Screening for bronchial carcinoma]D Moro-Sibilot, B Milleron,
Revue Des Maladies Respiratoires|December 13, 2005
[Chemotherapy for metastatic non-small cell lung cancer]M Pérol, D Moro-Sibilot
The European Respiratory Journal|April 2, 2009
First- and second-line therapy for advanced nonsmall cell lung cancerJ-P Sculier, D Moro-Sibilot
Revue Des Maladies Respiratoires|October 23, 2010
[Targeting insulin-like growth factors in the treatment of cancer]D Moro-Sibilot, M Coudurier, S Lantuejoul
Revue De Pneumologie Clinique|April 9, 2013
[Crizotinib: a targeted therapy in advanced ALK-positive non-small cell lung cancer]A-C Toffart, L Sakhri, D Moro-Sibilot
Pageof 8